Cargando…
Single-Dose Pharmacokinetics and Total Removal of Cyclophosphamide in a Patient with Acute Kidney Injury Undergoing Intermittent Haemodialysis and Prolonged Intermittent Kidney Replacement Therapy: A Case Report
The largest study on cyclophosphamide pharmacokinetics in dialysis patients comprises of 6 subjects. In the 2 decades since these data were obtained, dialyser membranes, treatment intensities, and treatment duration have changed considerably making new pharmacokinetic studies desirable. We aimed to...
Autores principales: | Lück, Catherina, Beutel, Gernot, Kühn-Velten, W. Nikolaus, Kielstein, Jan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359690/ https://www.ncbi.nlm.nih.gov/pubmed/37484798 http://dx.doi.org/10.1159/000531129 |
Ejemplares similares
-
Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations
por: Clajus, Christian, et al.
Publicado: (2013) -
Myocardial stunning occurs during intermittent haemodialysis for acute kidney injury
por: Mahmoud, Huda, et al.
Publicado: (2017) -
Intermittent high-volume predilution on-line haemofiltration versus standard intermittent haemodialysis in critically ill patients with acute kidney injury: a prospective randomized study
por: Škofic, Nataša, et al.
Publicado: (2012) -
How I prescribe prolonged intermittent renal replacement therapy
por: Clark, Edward G., et al.
Publicado: (2023) -
Conversion from Intermittent Hemodialysis to Peritoneal Dialysis in Metastatic Catheter-Related Bloodstream Infection
por: Ghandour, Mohamedanwar, et al.
Publicado: (2023)